Page last updated: 2024-10-24

dTMP catabolic process

Definition

Target type: biologicalprocess

The chemical reactions and pathways resulting in the breakdown of dTMP, deoxyribosylthymine monophosphate. [GOC:go_curators]

The dTMP catabolic process is the breakdown of deoxythymidine monophosphate (dTMP), a nucleotide that is a building block for DNA. This process occurs in both prokaryotic and eukaryotic cells and is essential for maintaining the integrity of DNA and ensuring proper cell function. Here's a detailed breakdown of the process:

1. **dTMP Kinase Activity:** dTMP is first phosphorylated to dTDP (deoxythymidine diphosphate) by the enzyme dTMP kinase. This reaction requires ATP as a phosphate donor.

2. **dTDP Kinase Activity:** Next, dTDP is further phosphorylated to dTTP (deoxythymidine triphosphate) by dTDP kinase. This reaction also requires ATP.

3. **Thymidine Phosphorylase Activity:** dTTP can be converted to thymidine (dThd) by the enzyme thymidine phosphorylase. This reaction requires inorganic phosphate (Pi) as a substrate.

4. **Thymidine Deaminase Activity:** Thymidine (dThd) is deaminated to deoxyuridine (dUrd) by the enzyme thymidine deaminase. This reaction removes the amino group from the thymine base.

5. **Deoxyuridine Phosphorylase Activity:** Deoxyuridine (dUrd) is then broken down to uracil and deoxyribose-1-phosphate (dRib-1-P) by the enzyme deoxyuridine phosphorylase. This reaction requires inorganic phosphate (Pi) as a substrate.

6. **Uracil Catabolism:** Uracil, the final product of dTMP catabolism, can be further metabolized through a variety of pathways. In some organisms, uracil is degraded to β-alanine and CO2, while in others, it is converted to dihydrouracil and ultimately to β-alanine.

The dTMP catabolic process is tightly regulated and integrated with other metabolic pathways. It is important for maintaining the correct balance of nucleotide pools, removing damaged or unwanted dTMP, and providing essential precursors for other biosynthetic pathways. Defects in enzymes involved in dTMP catabolism can lead to various metabolic disorders. For example, mutations in the thymidine phosphorylase gene can cause thymidine phosphorylase deficiency, which can result in neurological problems and immune dysfunction.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Uridine phosphorylase 1A uridine phosphorylase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q16831]Homo sapiens (human)
Thymidine phosphorylaseA thymidine phosphorylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P19971]Homo sapiens (human)

Compounds (25)

CompoundDefinitionClassesRoles
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
floxuridinefloxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
idoxuridineorganoiodine compound;
pyrimidine 2'-deoxyribonucleoside
antiviral drug;
DNA synthesis inhibitor
bromodeoxyuridineBromodeoxyuridine: A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
trifluridinetrifluridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-trifluoromethyluracil as the nucleobase. An antiviral drug used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis.

Trifluridine: An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
deoxyuridinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
doxifluridinedoxifluridine : A pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluorouracil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase.organofluorine compound;
pyrimidine 5'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
prodrug
captoprilcaptopril : A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.

Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
5-benzylacyclouridine5-benzyl-1-(2-hydroxyethoxymethyl)uracil : A pyrimidone that is uracil which is substituted by a 2-hydroxyethoxymethyl group at position 1 and a benzyl group at position 5.

5-benzylacyclouridine: structure given in first source
hydroxyether;
primary alcohol;
pyrimidone
6-aminothymine6-aminothymine: inhibits degradation of nucleosides (idoxuridine, thymidine) & pyrimidine bases
5-chloro-2'-deoxyuridine
5-(2-propenyl)-2'-deoxyuridine
edoxudinpyrimidine 2'-deoxyribonucleoside
3-cyano-6-hydroxy-4-methyl-2-pyridone3-cyano-6-hydroxy-4-methyl-2-pyridone: structure in first source
6-amino-5-bromouracil
5-hydroxymethyl-2'-deoxyuridinepyrimidine 2'-deoxyribonucleoside
5-formyl-2'-deoxyuridine5-formyl-2'-deoxyuridine: structure given in first source
2,6-dihydroxy-3-cyanopyridine2,6-dihydroxy-3-cyanopyridine: inhibitor of 5-fluorouracil degradation
5-nitro-2'-deoxyuridine
5-cyano-2'-deoxyuridine5-cyano-2'-deoxyuridine: structure in first source
ma-1tipiracil : A member of the class of pyrimidones that is uracil substituted by chloro and (2-iminopyrrolidin-1-yl)methyl groups at positions 5 and 6 respectively. Used (as the hydrochloride salt) in combination with trifluridine, a nucleoside metabolic inhibitor, for treatment of advanced/relapsed unresectable colorectal cancer.

tipiracil: inhibits thymidine phosphorylase
carboxamidine;
organochlorine compound;
pyrimidone;
pyrrolidines
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
5-(1-propenyl)-2'-deoxyuridine5-(1-propenyl)-2'-deoxyuridine: has anti-herpes activity; structure in first source
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloridetipiracil hydrochloride : A hydrochloride obtained by combining tipiracil with one equivalent of hydrochloric acid. Used in combination with trifluridine, a nucleoside metabolic inhibitor, for treatment of advanced/relapsed unresectable colorectal cancer.hydrochloride;
iminium salt
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
sesone7-deazaxanthine: structure in first source
5'-o-tritylinosine5'-O-tritylinosine: structure in first source